Activation of a renin-angiotensin system in ischemic cardiac sympathetic nerve endings and its association with norepinephrine release

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1965-1973

  Levi, Roberto ^a   Silver, Randi B ^a   Mackins, Christina J ^a   Seyedi, Nahid ^a   Koyama, Motohiro ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin; Arrhythmia; Bradykinin; Cardiac sympathetic nerve ending; Myocardial ischemia; Norepinephrine release; Renin

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; BILA 2157 BS; BRADYKININ; DESIPRAMINE; ENALAPRILAT; NORADRENALIN; NORADRENALIN TRANSPORTER; PEPSTATIN; RENIN; RENIN INHIBITOR; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR;

ACTIVE TRANSPORT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GUINEA PIG; HEART NERVE; HEART RIGHT ATRIUM; HUMAN; INCUBATION TIME; ISCHEMIC HEART DISEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; WESTERN BLOTTING; ADRENERGIC SYSTEM; ANIMAL; HEART ATRIUM; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION; SYNAPTOSOME;

ANIMALS; HEART ATRIA; HUMANS; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; SYNAPTOSOMES;

EID: 0036893284     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00148-0     Document Type: Article

References (30)

1. Bader M., Peters J., Baltatu O., Müller D.N., Luft F.C., Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J. Mol. Med. 79:2001;76-102.
2. Bauer J.H., Reams G.P. The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs. Arch. Intern. Med. 155:1995;1361-1368.
3. Berka J.L., Kelly D.J., Robinson D.B., Alcorn D., Marley P.D.et al. Adrenaline cells of the rat adrenal cortex and medulla contain renin and prorenin. Mol. Cell. Endocrinol. 119:1996;175-184.
4. Dostal D.E., Baker K.M. The cardiac renin-angiotensin system - conceptual, or a regulator of cardiac function? Circ. Res. 85:1999;643-650.
5. Duan J., Jaramillo J., Jung G.L., McLeod A.L., Fernandes B.H. A novel renal hypertensive guinea pig model for comparing different inhibitors of the renin-angiotensin system. J. Pharmacol. Toxicol. Methods. 35:1996;83-89.
6. 2 receptors. Circ. Res. 85:1999;919-930.
7. Guyene T.T., Devaux C., Menard J., Corvol P. Inhibition of human plasma renin activity by pepstatin. J. Clin. Endocrinol. Metab. 43:1976;1301-1306.
8. Hatta E., Maruyama R., Marshall S.J., Imamura M., Levi R. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts. J. Pharmacol. Exp. Ther. 288:1999;919-927.
9. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J. Pharmacol. Exp. Ther. 283:1997;494-500.
10. 2-adrenoceptors. Circ. Res. 78:1996;475-481.
11. 3-receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release. J. Pharmacol. Exp. Ther. 271:1994;1259-1266.
12. 3-receptors in the human heart. Circ. Res. 77:1995;206-210.
13. + exchange-structure, regulation, and its role in heart disease. Circ. Res. 85:1999;777-786.
14. Kimura E., Hashimoto K., Furukawa S., Hayakawa H. Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am. Heart J. 85:1973;635-647.
15. 1-adrenergic system and arrhythmias in ischaemic heart disease. Eur. Heart J. 12(Suppl. F):1991;88-98.
16. Lamontagne D., Nadeau R., Adam A. Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart. Br. J. Pharmacol. 115:1995;476-478.
17. 3-receptors: a new frontier in myocardial ischemia. J. Pharmacol. Exp. Ther. 292:2000;825-830.
18. 3-receptor agonists in myocardial infarction. Expert Opin. Investig. Drugs. 9:2000;2537-2542.
19. Maruyama R., Hatta E., Levi R. Norepinephrine release and ventricular fibrillation in myocardial ischemia/reperfusion: roles of angiotensin and bradykinin. J. Cardiovasc. Pharmacol. 34:1999;913-915.
20. 2 receptors. J. Pharmacol. Exp. Ther. 294:2000;248-262.
21. Matsuki T., Shoji T., Yoshida S., Kudoh Y., Motoe M.et al. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc. Res. 21:1987;428-432.
22. 1A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on noradrenaline release and changes in intracellular calcium. Neurosci. Lett. 199:1995;115-118.
23. Schömig A., Haass M., Richardt G. Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur. Heart J. 12(Suppl. F):1991;38-47.
24. Seyedi N., Koyama M., Mackins C.J., Levi R. Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release. J. Pharmacol. Exp. Ther. 302:2002;539-544.
25. Seyedi N., Maruyama R., Levi R. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release? J. Pharmacol. Exp. Ther. 290:1999;656-663.
26. 2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms. Circ. Res. 81:1997;774-784.
27. +-ATPase) activity in intercalated cells of cortical collecting duct. Am. J. Physiol., Renal Physiol. 279:2000;F195-F202.
28. Silver R.B., Choe H., Frindt G. Low-NaCl diet increases H-K-ATPase in intercalated cells from rat cortical collecting duct. Am. J. Physiol. 275:1998;F94-F102.
29. Simoneau B., Lavallee P., Anderson P.C., Bailey M., Bantle G.et al. Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy. Bioorg. Med. Chem. 7:1999;489-508.
30. Wirth K.J., Heitsch H., Schölkens B.A. Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharm. 73:1995;797-804.